Company Overview

For personal use only Company Overview Incannex is a global biotech company developing cannabinoid and psychedelic compound medicines. Our mission is to deliver novel drugs and therapies that transform the lives of patients currently experiencing unmet medical needs. We aim to develop targeted medicines at the cutting edge of biomedical science and cultural acceptance, creating long term benefit for both our targeted patients and shareholders who co-invest in our vision. - Listed on the ASX in 2016 - Listed on the NASDAQ in 2022 Incannex Investor Presentation 3

View entire presentation